The U.S. and German companies said in a statement that the doses come on top of the 300 million vaccine doses the bloc has initially ordere...

The bloc already lashed out Monday at pharmaceutical company AstraZeneca, accusing it of failing to guarantee the delivery of coronavirus v...

The EU has sealed six vaccine contracts for more than 2 billion doses, but only the Pfizer-BioNTech and Moderna vaccines have been approved...

Friday's announcement by the British pharmaceutical firm followed another last week by Pfizer, which said it would delay shipments of its v...

Britain has inoculated 3,857,266 people with a first dose and 449,736 with a second dose. On vaccines administered per 100 people, the Unit...

According to the statement, the companies plan to be back to the original schedule of deliveries to the European Union beginning the week o...

The protracted timetable, which was previously unknown, confirms that the bloc, with a population of 450 million, will need vaccines from o...

The vaccination drive kicked off at the weekend, with health workers and residents of care homes across the bloc among the first to get the...

A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion and could be finalized s...

The Food and Drug Administration on Friday approved an emergency use authorization for Moderna's vaccine, the second COVID-19 vaccine to re...

Moderna's vaccine is currently under review by Canada's drug regulator. The Pfizer/BioNTech vaccine received regulatory approval last week ...

The coronavirus vaccine, developed by Pfizer and its German partner BioNTech, gained emergency-use approval from federal regulators late on...

Bahrain plans to inoculate everyone 18 years and older in the kingdom at 27 different medical facilities, hoping to be able to vaccinate 10...

Pfizer, with partner BioNTech SE, and rival Moderna have released trial data showing their COVID-19 vaccines to be about 95% effective at p...

The vaccine's efficacy was found to be consistent across different ages and ethnicities - a promising sign given the disease has disproport...

The four states – Rhode Island, Texas, New Mexico, and Tennessee – were selected for the program because of their differences in overall si...

So far the US, UK, Australia, Japan, Qatar, Peru and Canada have already placed advance orders for the supply of Pfizer’s potential Covid-1...